Pfizer Inc (NYSE:PFE) shares, rose in value, with the stock price down by -0.12% to the previous day’s close as strong demand from buyers drove the stock to $25.44.
Actively observing the price movement in the recent trading, the stock is buoying the session at $25.47, falling within a range of $25.33 and $25.57. The value of beta (5-year monthly) is 0.615 whereas the PE ratio is 18.07 over 12-month period. Referring to stock’s 52-week performance, its high was $31.54, and the low was $24.48. On the whole, PFE has fluctuated by -3.67% over the past month.
With the market capitalization of Pfizer Inc currently standing at about $144.17 billion, investors are eagerly awaiting this quarter’s results, scheduled for in March. The company’s Forward Dividend Ratio is 1.69, with its dividend yield at 6.64%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 63B, with a low estimate of 13.94B and a high estimate of 15.25B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 14.37B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PFE’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of PFE currently trading nearly -2.90% and -2.86% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.30, while the 7-day volatility ratio is showing 2.06% which for the 30-day chart, stands at 2.14%. Furthermore, Pfizer Inc (PFE)’s beta value is 0.59, and its average true range (ATR) is 0.55.
A comparison of Pfizer Inc (PFE) with its peers suggests the former has fared considerably weaker in the market. PFE showed an intraday change of -0.12% in today’s session so far, and over the past year, it shrunk by -8.03%%.
Data on historical trading for Pfizer Inc (NYSE:PFE) indicates that the trading volumes over the past 10 days have averaged 42.8 and over the past 3 months, they’ve averaged 42.60 million. According to company’s latest data on outstanding shares, there are 5.67 billion shares outstanding.
Nearly 0.23% of Pfizer Inc’s shares belong to company insiders and institutional investors own 68.06% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 91.78 million shares as on 2025-01-15, resulting in a short ratio of 2.26. According to the data, the short interest in Pfizer Inc (PFE) stood at 162.00 of shares outstanding as of 2025-01-15; the number of short shares registered in 2024-12-13 reached 85.37 million. The stock has fallen by -4.11% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PFE stock heading into the next quarter.
